Impact of a package of health, nutrition, psychosocial support, and WaSH interventions delivered during preconception, pregnancy, and early childhood periods on birth outcomes and on linear growth at 24 months of age: factorial, individually randomised controlled trial.


Journal

BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488

Informations de publication

Date de publication:
26 10 2022
Historique:
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

To determine the effect of integrated and concurrent delivery of health, nutrition, water, sanitation and hygiene (WaSH), and psychosocial care interventions during the preconception period alone, during pregnancy and early childhood, and throughout preconception, pregnancy, and early childhood on birth outcomes and linear growth at 24 months of age compared with routine care. Individually randomised factorial trial. Low and middle income neighbourhoods of Delhi, India. 13 500 women were randomised to receive preconception interventions (n=6722) or routine care (n=6778). 2652 and 2269 pregnant women were randomised again to receive pregnancy and early childhood interventions or routine care. The analysis of birth outcomes included 1290 live births for the preconception, pregnancy, and early childhood interventions (group A), 1276 for the preconception intervention (group B), 1093 for the pregnancy and early childhood interventions (group C), and 1093 for the control (group D). Children aged 24 months by 30 June 2021 were included in the 24 month outcome analysis (453 in group A, 439 in B, 293 in C, and 271 in D). Health, nutrition, psychosocial care and support, and WaSH interventions were delivered during preconception, pregnancy, and early childhood periods. The primary outcomes were low birth weight, small for gestational age, preterm, and mean birth weight. At 24 months, the outcomes were mean length-for-age z scores and proportion stunted. Three prespecified comparisons were made: preconception intervention groups (A+B) versus no preconception intervention groups (C+D); pregnancy and early childhood intervention groups (A+C) versus routine care during pregnancy and early childhood (B+D) and preconception, pregnancy, and early childhood interventions groups (A) versus control group (D). The proportion with low birth weight was lower in the preconception intervention groups (506/2235) than in the no preconception intervention groups (502/1889; incidence rate ratio 0.85, 98.3% confidence interval 0.75 to 0.97; absolute risk reduction -3.80%, 98.3% confidence interval -6.99% to -0.60%). The proportion with low birth weight was lower in the pregnancy intervention groups (502/2096) than in the no pregnancy intervention groups (506/2028) but the upper limit of the confidence interval crossed null effect (0.87, 0.76 to 1.01; -1.71%, -4.96% to 1.54%). There was a larger effect on proportion with low birth weight in the group that received interventions in the preconception and pregnancy periods (267/1141) compared with the control group (267/934; 0.76, 0.62 to 0.91; -5.59%, -10.32% to -0.85%). The proportion stunted at 24 months of age was substantially lower in the pregnancy and early childhood intervention groups (79/746) compared with the groups that did not receive these interventions (136/710; 0.51, 0.38 to 0.70; -8.32%, -12.31% to -4.32%), and in the group that received preconception, pregnancy, and early childhood interventions (47/453) compared with the control group (51/271; 0.49, 0.32 to 0.75; -7.98%, -14.24% to -1.71%). No effect on stunting at 24 months was observed in the preconception intervention groups (132/892) compared with the no preconception intervention groups (83/564). An intervention package delivered during preconception, pregnancy, and early childhood substantially reduced low birth weight and stunting at 24 months. Pregnancy and early childhood interventions alone had lower but important effects on birth outcomes and 24 month outcomes. Preconception interventions alone had an important effect on birth outcomes but not on 24 month outcomes. Clinical Trial Registry-India CTRI/2017/06/008908.

Identifiants

pubmed: 36288808
doi: 10.1136/bmj-2022-072046
pmc: PMC9597398
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e072046

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Investigateurs

Farhana Rafiqui (F)
Jasmine Kaur (J)
Medha Shekhar (M)
Anita Kate (A)
Gunjan Aggarwal (G)
Runa Ghosh (R)
Ratan Shekhawat (R)
Kunal Kishore (K)
Navneet Mehra (N)
Nikita Arya (N)
Ritu Chaudhary (R)
Anuradha Tamaria (A)
Savita Sapra (S)
Tivendra Kumar (T)
Sowmya Prakash (S)
Poornima Modi (P)
Neelam Kaur (N)
Neha Tyagi (N)
Geeta Mehto (G)
Afifa Khatun (A)
Sayeed Ahmed (S)
Aparna Singh (A)
Gulafshan Ansari (G)
Ramanjeet Kaur (R)
Manisha Gupta (M)
Girish Chand Pant (GC)
Ankita Dutta (A)
Deepak More (D)
Mukesh Kumar (M)
Sabreen Siraj (S)
Farah Abbasi (F)
Heena Chaudhary (H)
Karishma Sharma (K)
Sonia Kuruvilla (S)
Anjali Chandra (A)
Sugandha Arya (S)
Pradeep Debata (P)
Anita Yadav (A)
K C Aggarwal (KC)
Sujata Das (S)
Abhinav Jain (A)
Rahul Sachdev (R)
Omprakash Bansal (O)
Raghav Aggarwal (R)

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the Biotechnology Industry Research Assistance Council of the Department of Biotechnology, Government of India and Bill and Melinda Gates Foundation, USA for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Références

Am J Clin Nutr. 2017 Oct;106(4):1070-1077
pubmed: 28835364
J Nutr. 2017 Nov;147(11):2169S-2178S
pubmed: 28904113
Matern Child Nutr. 2015 Oct;11(4):415-32
pubmed: 25857334
BMC Med Res Methodol. 2018 Jul 20;18(1):81
pubmed: 30029629
Am J Clin Nutr. 2020 Sep 14;112(Suppl 2):777S-791S
pubmed: 32860401
Trials. 2020 Jan 31;21(1):127
pubmed: 32005294
Cochrane Database Syst Rev. 2018 May 18;5:CD011768
pubmed: 29775501
Indian Pediatr. 2017 Jul 15;54(7):567-573
pubmed: 28737142
Am J Clin Nutr. 2019 Feb 1;109(2):457-469
pubmed: 30721941
Lancet. 2005 May 7-13;365(9471):1657-61
pubmed: 15885299
J Nutr. 2016 Jul;146(7):1445S-52S
pubmed: 27281806
Reprod Health. 2014 Sep 26;11 Suppl 3:S3
pubmed: 25415364
Int J Epidemiol. 2013 Oct;42(5):1340-55
pubmed: 23920141
Biometrics. 1979 Sep;35(3):549-56
pubmed: 497341
Bull World Health Organ. 2017 Aug 01;95(8):574-583
pubmed: 28804169
Nutrients. 2020 Mar 10;12(3):
pubmed: 32164187
J Pediatr (Rio J). 2015 Jul-Aug;91(4):326-32
pubmed: 25913048
Lancet. 2018 May 5;391(10132):1842-1852
pubmed: 29673874
BMC Public Health. 2013;13 Suppl 3:S13
pubmed: 24564534
Reprod Health. 2014;11 Suppl 1:S2
pubmed: 25178042
Lancet Glob Health. 2019 Aug;7(8):e1139-e1146
pubmed: 31303300
Cochrane Database Syst Rev. 2015 Jul 22;(7):CD004736
pubmed: 26198451
Matern Child Nutr. 2016 May;12 Suppl 1:12-26
pubmed: 27187907
Lancet Glob Health. 2017 Nov;5(11):e1090-e1100
pubmed: 29025632
BMC Pediatr. 2019 Jan 29;19(1):35
pubmed: 30696415
Matern Child Nutr. 2013 Sep;9 Suppl 2:27-45
pubmed: 24074316
Cochrane Database Syst Rev. 2020 Jul 25;7:CD012241
pubmed: 32710657
PLoS Med. 2022 May 13;19(5):e1004002
pubmed: 35560315
Physiol Rev. 2014 Oct;94(4):1027-76
pubmed: 25287859
Cochrane Database Syst Rev. 2015 Aug 07;(8):CD000490
pubmed: 26252501
BMJ Glob Health. 2022 Aug;7(8):
pubmed: 35948345
JAMA Netw Open. 2019 Jul 3;2(7):e197871
pubmed: 31348509
Lancet Glob Health. 2019 Jul;7(7):e849-e860
pubmed: 31103470
Lancet. 2018 May 5;391(10132):1830-1841
pubmed: 29673873
PLoS Med. 2016 May 10;13(5):e1002018
pubmed: 27163787

Auteurs

Sunita Taneja (S)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Ranadip Chowdhury (R)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Neeta Dhabhai (N)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Ravi Prakash Upadhyay (RP)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Sarmila Mazumder (S)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Sitanshi Sharma (S)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Kiran Bhatia (K)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Harish Chellani (H)

Department of Pediatrics, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

Rupali Dewan (R)

Department of Obstetrics & Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

Pratima Mittal (P)

Department of Obstetrics & Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

M K Bhan (MK)

Knowledge Integration and Translational Platform (KnIT), Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India, New Delhi, India.

Rajiv Bahl (R)

Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland.

Nita Bhandari (N)

Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH